Autosomal Dominant Charcot-Marie-Tooth Disease Type 2 Due to MARS (Methionyl-tRNA Synthetase 1) Mutation

Autosomal dominant Charcot-Marie-Tooth disease type 2 due to MARS (methionyl-tRNA synthetase 1) mutation is a very rare, inherited nerve disease. It mainly damages the long nerves in the legs and arms (peripheral nerves). These nerves carry signals from the brain and spinal cord to the muscles and back from the skin to the brain. When they do not work well, the person develops weakness, loss of feeling, and foot and hand problems. This condition belongs to the “axonal” group of Charcot-Marie-Tooth diseases, called CMT type 2 (CMT2). In axonal CMT, the main problem is in the nerve fibre (axon) itself, not in the myelin covering around the nerve. NINDS+1

Autosomal dominant Charcot-Marie-Tooth disease type 2 due to MARS mutation is a very rare inherited nerve disease. It is also called CMT2U, caused by a change (mutation) in the MARS1 gene, which makes the enzyme methionyl-tRNA synthetase. This enzyme helps cells build proteins. When the gene is faulty, the long nerves in the legs and arms slowly become damaged. This leads to weakness, thin muscles, foot deformities, balance problems, and reduced feeling in the feet and hands. The condition is “autosomal dominant,” which means a person can get it if they inherit one changed gene from one parent.PMC+3PMC+3Nature+3

How this disease affects the body

In CMT2U, the problem is mainly in the axons, which are the long “wires” of the nerve cells. Over time, these axons cannot carry electrical signals properly to the muscles and from the skin. The result is slowly worsening weakness in the feet and legs first, then sometimes in the hands. People can have foot drop, high arched feet, frequent tripping, numbness, burning or electric-like pain, and loss of reflexes. Most cases progress slowly and usually do not shorten life, but disability and fatigue can be important. At the moment, there is no cure or gene-based medicine for MARS-related CMT2, so treatment focuses on keeping muscles strong, protecting joints, managing pain, and preventing falls and deformities.Charcot-Marie-Tooth Association+2Mayo Clinic+2

The MARS1 gene gives the instructions to make the enzyme methionyl-tRNA synthetase. This enzyme is needed for normal protein building in all cells. Harmful (pathogenic) changes in one copy of the MARS1 gene can cause a form of axonal CMT known as CMT2U. In most families, the disease passes in an autosomal dominant pattern, which means one changed copy of the gene from either parent is enough to cause the disease. The illness usually progresses slowly over many years. Nature+2PubMed+2

In people with CMT2U, weakness and wasting often begin in the feet and lower legs, then slowly spread to the hands and forearms. Many patients develop high-arched feet, difficulty walking, and problems with balance and fine finger movements. Symptoms may begin in late childhood, teenage years, or adulthood, but some reported cases have earlier onset. The condition is life-long but rarely affects life span; it mainly affects comfort, mobility, and independence. Mayo Clinic+2Cleveland Clinic+2

Other names

Charcot-Marie-Tooth diseases often have many names. Below are some other names or closely related labels that may be used for this specific condition.

1. Charcot-Marie-Tooth disease, axonal, type 2U (CMT2U) – This is the formal subtype name often used in research papers and rare disease databases. It tells us the disease is an axonal CMT (type 2) and that this particular form is labeled “U.” MalaCards+1

2. Autosomal dominant Charcot-Marie-Tooth disease type 2U – This name adds the inheritance pattern (“autosomal dominant”). It highlights that one faulty copy of the gene is enough to cause symptoms. MalaCards+1

3. MARS1-related Charcot-Marie-Tooth disease type 2 – This name focuses on the gene. It tells us that the disease is a CMT2 type caused by mutations in the MARS1 gene. Nature+2Orpha.net+2

4. MARS-associated hereditary motor and sensory neuropathy – “Hereditary motor and sensory neuropathy” is another general phrase for CMT. Here it is used to show that both movement (motor) and feeling (sensory) nerves are affected and that the cause is a MARS1 mutation. NINDS+2ScienceDirect+2

5. MARS-related axonal sensorimotor polyneuropathy – Some scientific articles describe the condition this way. “Polyneuropathy” means many nerves are affected. “Sensorimotor” means both sensory and motor nerves are involved. “Axonal” indicates the axons are primarily damaged. PubMed+1

Types

This condition is a single genetic subtype (CMT2U), but doctors sometimes talk about different “types” of presentation or clinical pattern. These are not official genetic subtypes but are useful to describe how the disease looks in different people. Europe PMC+1

1. Typical adult-onset CMT2U – In many reported patients, symptoms begin in adulthood with slowly progressive weakness and wasting in the feet and legs. Over years, hands may become weak as well. This is the “classic” slowly progressive axonal sensorimotor neuropathy linked to MARS1 mutations. PubMed+1

2. Early-onset or congenital CMT2U – A few cases describe symptoms starting in infancy or early childhood. Babies may have delayed motor milestones (for example late sitting or walking), low muscle tone, and early foot deformities. These cases show that MARS1-related neuropathy can sometimes present very early. Institut Myologie+1

3. Motor-predominant CMT2U – In some people, muscle weakness and wasting are the most obvious features, with less sensory loss. These patients may mainly complain of foot drop, frequent tripping, and hand weakness rather than numbness or tingling. NINDS+2Europe PMC+2

4. Sensorimotor CMT2U with sensory loss – Other individuals have clear sensory symptoms such as numbness, reduced vibration sense, or burning pain in the feet and hands. Nerve conduction studies often show reduced responses in both sensory and motor nerves. NINDS+2Europe PMC+2

5. MARS-related disorders outside classic CMT – Very rarely, when both copies of MARS are mutated (homozygous or compound heterozygous), children may develop a different severe disease with lung and liver involvement called interstitial lung and liver disease (ILLD). This is not typical CMT2U but shows that the same gene can cause different diseases depending on the mutation pattern. Nature+1

Causes

For this disease, the direct cause is always a harmful mutation in the MARS1 gene. All the “causes” below are different ways to describe that genetic problem and factors that influence how the disease appears.

1. Pathogenic MARS1 mutation – The main cause is a disease-causing change in one copy of the MARS1 gene. This mutation alters the structure or function of methionyl-tRNA synthetase and leads to nerve damage over time. Nature+2PubMed+2

2. Autosomal dominant inheritance – In many families, the mutation is inherited from an affected parent in an autosomal dominant way. Each child of an affected parent has a 50% chance of inheriting the faulty gene and therefore the risk of developing the disease. NINDS+2ARUP Consult+2

3. De novo (new) mutation – Sometimes the MARS1 mutation happens for the first time in the affected person, with no previous family history. This “new” mutation in a sperm or egg cell still causes autosomal dominant disease in that person and can be passed to future children. NINDS+2ScienceDirect+2

4. Missense mutations in enzyme active sites – Many reported MARS1 mutations change a single amino acid (missense mutation) in key parts of the enzyme. This can reduce its ability to attach methionine to tRNA, which interferes with normal protein production in nerve cells. Nature+2PubMed+2

5. Loss of normal enzyme function (loss of function) – Some mutations cause loss of function, where the enzyme does not work as it should. Even partial loss can stress nerve cells that have high energy and protein needs, making them more likely to degenerate. Nature+2ScienceDirect+2

6. Toxic gain-of-function effects – In some genetic neuropathies, mutant proteins not only lose normal function but also gain harmful new activities. For aminoacyl-tRNA synthetases like MARS, abnormal interactions or misfolded proteins may harm nerve cells, even when some normal enzyme activity remains. ResearchGate+1

7. Disturbed protein synthesis in neurons – Neurons need constant, precise protein production to maintain long axons. Faulty MARS1 disrupts the first step in protein building (charging tRNA with methionine), which can lead to misfolded or missing proteins in peripheral nerves. Nature+2ScienceDirect+2

8. Axonal vulnerability due to long nerve length – The longest nerves (for example to the feet) are most vulnerable to problems in transport and protein supply. This is why symptoms usually start in the feet and legs when axons are damaged by MARS1 mutations. Europe PMC+2ScienceDirect+2

9. Secondary damage to Schwann cells and myelin – Although CMT2U is mainly an axonal neuropathy, chronic axonal injury can also stress Schwann cells that support the axons. Over time, mild myelin changes may appear as a secondary effect. Europe PMC+2Wikipedia+2

10. Mitochondrial stress and energy problems – Some CMT2 genes affect mitochondrial function. For MARS1, disturbed protein synthesis can also affect mitochondrial proteins, leading to poor energy supply in nerve cells and making them more likely to degenerate. ScienceDirect+2Nature+2

11. Endoplasmic reticulum (ER) stress and unfolded protein response – Misfolded MARS1 protein or misfolded proteins produced because of the faulty enzyme can build up in the cell. This can trigger ER stress and the unfolded protein response, which may eventually lead to cell death in vulnerable neurons. ScienceDirect+1

12. Impaired axonal transport – Axonal health depends on moving important materials along the nerve. When proteins are not produced or folded correctly, transport of needed cargo along the axon can slow or fail, leading to “dying back” of the longest nerve fibres. Europe PMC+2ScienceDirect+2

13. Genetic background (modifier genes) – Other genes in the person’s genome may modify how severe the MARS1-related neuropathy becomes. These “modifier” genes can partly explain why some people with similar mutations are mildly affected while others are more disabled. Europe PMC+2ARUP Consult+2

14. Age-related cumulative damage – Because the disease is slowly progressive, years of minor axonal damage add up. As a person ages, the cumulative effect of the mutation leads to more obvious weakness, foot deformity, and balance problems. NINDS+2Cleveland Clinic+2

15. Mechanical stress on weak muscles and joints – Weak muscles around the ankle and foot change how a person walks. This causes extra strain on certain tendons and joints. Over time, this mechanical stress worsens deformities and disability, even though the root cause is still the gene mutation. Mayo Clinic+1

16. Lifestyle factors (for example inactivity) – Lack of physical activity does not cause the genetic disease, but it can worsen muscle wasting and stiffness in someone who already has CMT2U. Appropriate exercise and physiotherapy may help slow functional decline. NINDS+2Cleveland Clinic+2

17. Additional nerve toxins (for example neurotoxic drugs) – Certain drugs (such as some chemotherapy agents) are known to damage peripheral nerves. In someone with CMT2U, exposure to these medications may worsen neuropathy because their nerves are already fragile. NINDS+2BMJ Best Practice+2

18. Metabolic stress (for example poorly controlled diabetes) – Diabetes itself can cause peripheral neuropathy. If a person with MARS1-related CMT develops diabetes, the diabetic nerve damage can add to the inherited neuropathy, making symptoms much worse. NINDS+2ScienceDirect+2

19. Nutritional deficiencies – Severe, long-lasting lack of certain vitamins (such as vitamin B12 or thiamine) can injure peripheral nerves. While these do not cause CMT2U, they can add to the genetic damage if present, so maintaining good nutrition is important. NINDS+2BMJ Best Practice+2

20. Other health conditions affecting nerves – Co-existing illnesses such as chronic kidney disease, autoimmune neuropathies, or alcohol misuse can also harm nerves. In a person with CMT2U, these additional problems may speed up nerve damage and disability. NINDS+2BMJ Best Practice+2

Symptoms

1. Foot weakness and foot drop – Weakness of the muscles that lift the front of the foot is very common. The person may drag the toes or have “foot drop,” which makes walking on uneven ground difficult and causes frequent tripping. Mayo Clinic+2Cleveland Clinic+2

2. High-arched feet (pes cavus) – Many people develop a very high arch and curled toes (hammertoes). These changes are caused by muscle imbalance: some muscles become weak while others remain relatively strong, pulling the bones into a new shape. Cleveland Clinic+1

3. Muscle wasting in lower legs (“stork legs”) – Over time, the muscles of the calves become thin because the nerves cannot fully activate them. The legs may look skinny with less muscle bulk, giving the classic “stork leg” or “inverted champagne bottle” appearance. NINDS+2Cleveland Clinic+2

4. Difficulty with balance and walking – Because both strength and sensation in the feet are reduced, many patients have poor balance, especially in the dark or on uneven surfaces. They may walk with a high-stepping gait to avoid tripping. NINDS+2Cleveland Clinic+2

5. Frequent tripping and falls – Foot drop, poor balance, and ankle instability lead to repeated tripping, ankle sprains, and falls. This can make people afraid of walking outside or doing sports. Mayo Clinic+2Cleveland Clinic+2

6. Numbness and reduced feeling in feet and toes – Damage to sensory nerves reduces the ability to feel light touch, pain, or temperature in the feet and toes. People may not notice small cuts or pressure areas on their feet. NINDS+2Cleveland Clinic+2

7. Pins-and-needles or burning pain – Some individuals experience uncomfortable sensations such as tingling, “pins and needles,” burning, or electric-shock-like pains in the feet, and later in the hands. This is called neuropathic pain. NINDS+2Cleveland Clinic+2

8. Loss of vibration and position sense – The ability to feel vibration (tested with a tuning fork) and to know where the feet are in space without looking (position sense) becomes reduced. This further worsens balance, especially when the eyes are closed. NINDS+2Charcot-Marie-Tooth Association+2

9. Absent or reduced ankle reflexes – On examination, tendon reflexes at the ankles (and sometimes knees) are weak or absent because the reflex arc relies on healthy peripheral nerves. Many people do not feel this themselves; it is usually found by the doctor. NINDS+2BMJ Best Practice+2

10. Hand weakness and poor fine motor skills – As the disease progresses, weakness and wasting can affect the small muscles of the hands. Patients may have trouble with tasks that need fine control, such as buttoning clothes, writing, or using tools. NINDS+2Cleveland Clinic+2

11. Clumsiness in childhood – Children who later receive a CMT2 diagnosis are often described as “clumsy.” They may be slow to run, easily trip, or struggle to keep up with peers in sports. BMJ Best Practice+2NINDS+2

12. Leg cramps and fatigue – Weak, overworked muscles can cramp easily. People often complain of leg tiredness after walking short distances, especially if they must lift their feet higher to avoid tripping. NINDS+2Cleveland Clinic+2

13. Skeletal deformities of the spine – Some individuals with CMT develop mild spinal deformities such as scoliosis (curving of the spine), especially if muscle imbalance around the trunk is present from a young age. Wikipedia+2NINDS+2

14. Cold, discolored feet – Because of poor nerve control of blood vessels and reduced activity, the feet can appear cold or slightly blue. This symptom is not specific but is common in many peripheral neuropathies. NINDS+2ScienceDirect+2

15. Emotional impact and reduced quality of life – Chronic weakness, visible deformities, pain, and fear of falling can lead to low mood, anxiety, or social withdrawal. Although this is not a direct nerve symptom, it is an important part of the overall disease burden. NINDS+2CMT Research Foundation+2

Diagnostic tests

Doctors diagnose autosomal dominant CMT2 due to MARS mutation by combining clinical examination, electrodiagnostic studies, and genetic testing. They also use tests to rule out other causes of neuropathy. NINDS+2Charcot-Marie-Tooth Association+2

Physical examination tests

1. General neurological examination – The doctor looks for muscle weakness, wasting, changes in muscle tone, and abnormal movements in the arms and legs. This helps confirm that the problem is in the peripheral nerves rather than in the brain or spinal cord. NINDS+2BMJ Best Practice+2

2. Gait and walking assessment – The patient is asked to walk in a straight line, on heels, and on toes. A high-stepping gait, foot drop, and poor balance are clues that point to CMT rather than other conditions. NINDS+2BMJ Best Practice+2

3. Muscle strength grading in legs and arms – The doctor grades strength of specific muscles (for example ankle dorsiflexors, toe extensors, hand interossei) using standard scales. Distal (far from the trunk) weakness with relatively preserved proximal strength suggests CMT2. Europe PMC+2BMJ Best Practice+2

4. Examination of foot posture and deformities – The shape of the feet is carefully inspected for high arches, hammertoes, heel varus, or flat feet. These structural changes develop gradually due to long-standing muscle imbalance in hereditary neuropathies. Cleveland Clinic+2Wikipedia+2

5. Reflex testing – Using a reflex hammer, the examiner checks ankle, knee, and upper limb tendon reflexes. Reduced or absent ankle reflexes in both legs strongly support a peripheral neuropathy such as CMT2U. NINDS+2BMJ Best Practice+2

Manual bedside tests

6. Manual muscle testing (MMT) – The examiner applies resistance with their hands to test individual muscles in detail. This bedside test helps map which muscles are weak and shows the typical distal greater than proximal pattern seen in CMT2. Europe PMC+1

7. Pinprick and light touch testing – Using a cotton swab or single-use pin, the doctor compares feeling in different skin areas. Reduced response in a “stocking and glove” pattern (feet then hands) is typical of length-dependent axonal neuropathies. NINDS+2Charcot-Marie-Tooth Association+2

8. Vibration sense testing with a tuning fork – A vibrating tuning fork is placed on bony points such as the big toe and ankle. Early loss of vibration sense in the feet is common in CMT and other peripheral neuropathies. NINDS+2BMJ Best Practice+2

9. Proprioception (joint position) testing – The examiner moves the patient’s toes or fingers up and down and asks the patient to say which direction. Difficulty sensing movement at the toes but not at the knees supports distal sensory nerve involvement. NINDS+2BMJ Best Practice+2

10. Romberg test for balance – The patient stands with feet together and then closes the eyes. Increased swaying or loss of balance when the eyes are closed shows that sensory input from the feet is poor and that the person relies heavily on vision to stay upright. BMJ Best Practice+2NINDS+2

Laboratory and pathological tests

11. Basic blood tests to rule out other neuropathies – Tests such as blood sugar, vitamin B12 level, kidney and liver function, and thyroid function are usually checked to rule out common acquired causes of neuropathy. Normal results support a hereditary cause such as CMT2U. NINDS+2ARUP Consult+2

12. Tests for autoimmune or inflammatory neuropathies – In selected cases, doctors may check markers of autoimmune disease or infections (for example ANA, ESR, specific antibodies) to exclude treatable inflammatory neuropathies. If these are negative, inherited neuropathy becomes more likely. NINDS+2ARUP Consult+2

13. Genetic panel testing for CMT – A targeted CMT gene panel looks at many known CMT genes at the same time, including MARS1. Finding a known pathogenic MARS1 variant in a person with typical clinical and electrophysiological features confirms the diagnosis of MARS-related CMT2U. ARUP Consult+2Charcot-Marie-Tooth Association+2

14. Single-gene sequencing of MARS1 – If a CMT panel is not available or if clinical suspicion is very high, the laboratory can sequence the coding regions of MARS1 alone. Detection of a rare, clearly pathogenic variant in MARS1 that fits the family pattern gives a definite genetic diagnosis. Nature+2PubMed+2

15. Exome or genome sequencing – In complex or unsolved cases, broader exome or genome sequencing may be used. This approach has helped discover MARS1 as a CMT2U gene in the first place and can detect unusual or new variants in patients with unexplained neuropathy. PubMed+2ScienceDirect+2

16. Nerve biopsy (rarely) – A small piece of a peripheral nerve (usually the sural nerve in the leg) may be removed for microscopic study. In CMT2U, findings would show axonal degeneration more than demyelination. Today, nerve biopsy is used less often because genetic testing is more accurate and less invasive. Europe PMC+2ARUP Consult+2

Electrodiagnostic tests

17. Nerve conduction studies (NCS) – Electrodes are used to stimulate nerves and record responses. In CMT2U, nerve conduction velocities are often near normal or only mildly slowed, but the size of the responses (amplitudes) is reduced, which is typical of axonal neuropathy. This helps classify the disease as type 2 rather than type 1 (demyelinating). Europe PMC+2Charcot-Marie-Tooth Association+2

18. Electromyography (EMG) – A fine needle electrode is inserted into muscles to record electrical activity. EMG in CMT2U usually shows signs of chronic denervation and re-innervation, confirming that motor nerves have been slowly damaged over time. Europe PMC+2BMJ Best Practice+2

Imaging tests

19. Foot and ankle X-rays – X-rays can show bony deformities such as high arches, hammertoes, and joint misalignment. These images help orthopedic surgeons plan braces or corrective surgery if needed, even though they do not show the nerves themselves. Cleveland Clinic+2Mayo Clinic+2

20. Spine and limb MRI (in selected cases) – Magnetic resonance imaging is sometimes used to look at muscles and the spine. It can show patterns of muscle wasting and rule out other structural causes of weakness, such as spinal cord compression. In research settings, MRI can also show changes in peripheral nerves. Europe PMC+2BMJ Best Practice+2

Non-pharmacological treatments (therapies and other approaches)

Below are 10 key non-drug therapies. In real life, a person may use several of them together in a long-term plan.

1. Physiotherapy (physical therapy)
   Physiotherapy uses special exercises and hands-on techniques to keep muscles flexible and as strong as possible. A therapist teaches gentle stretching, strengthening of weak muscles, balance exercises, and safe walking practice. Regular sessions can slow down contractures (permanent muscle tightening), reduce stiffness, and improve endurance. Home exercise programs and low-impact activities like swimming or cycling are often included. Physiotherapy does not cure the gene problem, but it helps the body work around it and reduces disability over time.MDPI+4Physiopedia+4PMC+4

2. Orthotic devices (AFOs and braces)
   Many people with CMT2U develop foot drop and ankle instability. Ankle-foot orthoses (AFOs) and other braces support the foot and ankle in a more normal position. This makes walking safer, reduces tripping, and lowers energy use. Modern lightweight carbon or plastic AFOs can fit inside regular shoes and may feel like an extension of the leg rather than a bulky device. Correct bracing can delay joint deformity and help people walk further with less pain and fatigue.Charcot-Marie-Tooth Association+2ScienceDirect+2

3. Occupational therapy (OT)
   Occupational therapists help people manage daily activities such as dressing, bathing, cooking, school work, and using computers. When hand weakness or reduced sensation appears, they can suggest adaptive tools (built-up pens, special cutlery, button hooks, etc.). They also teach energy-saving strategies so that people do not get exhausted. OT can make a big difference in independence, education, and work participation even when muscle strength cannot be fully restored.ScienceDirect+1

4. Custom footwear and insoles
   Because the disease affects foot shape (high arches, claw toes, flat feet, or deformities), special shoes and orthotic insoles can spread pressure more evenly and reduce pain. A podiatrist or orthotist can design shoes with extra depth, soft uppers, and firm heel counters to control the ankle. Well-fitted footwear lowers the risk of calluses, skin breakdown, falls, and long-term joint damage. It also makes braces more comfortable to wear every day.nhs.uk+2ScienceDirect+2

5. Balance and gait training
   Many people with CMT2U have poor balance and a high risk of falls. Therapists can design balance programs using simple tools like balance boards, foam pads, or parallel bars. They teach safe walking patterns, how to turn, how to use railings and grab bars, and how to recover from a small loss of balance. Over time, this training can reduce fear of falling, improve confidence in public spaces, and help maintain independence at home and outside.PMC+2ScienceDirect+2

6. Pain self-management techniques
   Along with medicines, non-drug methods like heat packs, cold packs, gentle massage, relaxation breathing, and pacing activities can ease muscle and joint pain. Learning how to rest before pain flares, keeping a sleep routine, and using ergonomic chairs or cushions can reduce daily discomfort. A pain management team can teach cognitive-behavioral strategies to handle chronic pain more calmly and reduce constant worry or stress about symptoms.nhs.uk+1

7. Psychological support and counseling
   Living with a chronic genetic disease can cause low mood, anxiety, or frustration about physical limits. Psychologists or counselors can help people process these feelings, develop coping skills, and protect mental health. Support groups (online or in person) allow patients and families to share experiences and practical tips. Good emotional health makes it easier to stick to exercise programs and attend regular appointments.Muscular Dystrophy Association+1

8. Genetic counseling and family planning help
   Because this disease is autosomal dominant, there is a 50% chance of passing the gene change to children. Genetic counselors explain inheritance, testing options for family members, and possible reproductive options such as IVF with pre-implantation genetic testing where available. This does not change the patient’s health but gives the family clear information and time to plan.MalaCards+1

9. Workplace and school adaptations
   Simple changes like adjustable desks, voice-to-text software, flexible schedules, and avoidance of heavy lifting can help people with CMT2U stay in school and work. Occupational health teams can advise employers and teachers about safe tasks and reasonable adjustments. Early planning limits strain and reduces the risk of injury caused by demanding physical jobs.ScienceDirect+1

10. Regular multidisciplinary follow-up
    Best care usually involves a team: neurologist, physiotherapist, occupational therapist, podiatrist, orthotist, pain specialist, and sometimes orthopedic surgeon. Regular follow-up allows early detection of new problems such as worsening foot deformity, scoliosis, severe pain, or mood changes. Adjusting braces, exercise plans, and medicines at the right time can delay complications and keep quality of life higher for longer.ScienceDirect+2Mayo Clinic+2

---

Drug treatments (medicines)

There is no medicine that fixes the MARS gene or cures CMT2U today. Medicines are used to treat symptoms such as nerve pain, muscle or joint pain, sleep problems, and mood difficulties. Most drugs are borrowed from other neuropathic pain conditions like diabetic neuropathy or post-herpetic neuralgia, where good trials exist and FDA labels are available. Always remember that doses below are examples from labels and general practice, not personal prescriptions.

1. Gabapentin (Neurontin, Gralise)
   Gabapentin is an anti-seizure medicine widely used for nerve pain. FDA labels show it is approved for post-herpetic neuralgia and partial seizures, and has proven benefit in several neuropathic pain models.FDA Access Data+3FDA Access Data+3FDA Access Data+3 In adults, treatment for neuropathic pain often starts around 300 mg at night and gradually increases, sometimes up to 1800–3600 mg per day in divided doses, depending on kidney function and tolerance. It works by binding to calcium channels in nerve cells and reducing the release of pain-signal chemicals. Common side effects include sleepiness, dizziness, and swelling of legs.

2. Pregabalin (Lyrica)
   Pregabalin is a related drug approved by the FDA for neuropathic pain linked to diabetic peripheral neuropathy and post-herpetic neuralgia, and for fibromyalgia and certain seizures.FDA Access Data+3FDA Access Data+3FDA Access Data+3 For adults with neuropathic pain, doctors often use total daily doses between about 150 and 300 mg, sometimes higher, split into two or three doses or in an extended-release form. It reduces pain by decreasing the release of neurotransmitters involved in pain pathways. Dizziness, drowsiness, weight gain, and ankle swelling are frequent side effects, and it is a controlled drug in many countries.

3. Duloxetine (Cymbalta)
   Duloxetine is an antidepressant that also treats nerve pain. FDA labeling shows it is approved for neuropathic pain from diabetic peripheral neuropathy, fibromyalgia, and chronic musculoskeletal pain.FDA Access Data+4FDA Access Data+4FDA Access Data+4 A typical adult dose for neuropathic pain is 60 mg once daily, sometimes starting at 30 mg to improve tolerance. It blocks reuptake of serotonin and noradrenaline, which can dampen pain signals in the spinal cord and brain. Nausea, dry mouth, sleepiness, sweating, and raised blood pressure are important possible side effects.

4. Tricyclic antidepressants (for example amitriptyline)
   Amitriptyline is an older antidepressant that also helps some people with nerve pain at low doses. FDA labeling focuses on depression and other psychiatric indications, but it is widely used off-label for peripheral neuropathic pain.FDA Access Data+2FDA Access Data+2 For pain, doctors often use small doses at night (for example 10–25 mg) and adjust slowly upward as needed. It works by increasing serotonin and noradrenaline in pain pathways and by blocking certain ion channels. Side effects include dry mouth, constipation, blurred vision, sleepiness, and sometimes heart rhythm changes, so it must be used carefully.

5. NSAIDs such as naproxen or ibuprofen
   Non-steroidal anti-inflammatory drugs (NSAIDs) do not treat nerve damage itself but can help with muscle and joint pain caused by abnormal walking and muscle imbalance. FDA labels for naproxen state it is used for arthritis and other musculoskeletal pain and has important stomach and bleeding warnings.FDA Access Data+3nhs.uk+3FDA Access Data+3 Doses and timing depend on the specific product, and long-term use must be carefully monitored because of risks to the stomach, kidneys, and heart.

6. Tramadol (and similar strong painkillers – used very cautiously)
   Tramadol is an opioid-like pain reliever sometimes used when pain is severe and other medicines fail. FDA labels warn about serious risks like addiction, overdose, breathing problems, and seizures.FDA Access Data+3FDA Access Data+3FDA Access Data+3 Because of these dangers, tramadol and similar drugs are usually reserved for short-term use under close medical supervision, and are not first-line choices in CMT. For a teenager, doctors tend to avoid these unless there is no safer option.

7. Topical pain treatments (creams, gels, patches)
   Some people find partial relief from topical lidocaine or capsaicin products applied over local painful areas. These products can reduce over-active pain fibers in the skin. They avoid many whole-body side effects of oral drugs but may cause local burning or numbness. High-strength patches need a prescription and careful use. Evidence mainly comes from other neuropathic conditions but can be applied by analogy to inherited neuropathy.

8. Medicines for muscle cramps or spasticity
   If muscle cramps are prominent, doctors sometimes use drugs like baclofen or tizanidine, which relax muscles by acting on the spinal cord. These do not treat axonal damage but can reduce painful spasms and improve sleep. They may cause drowsiness, dizziness, or liver enzyme changes, so monitoring is needed.

9. Medicines for mood and sleep
   Depression, anxiety, or chronic insomnia can make pain feel worse. In those cases, selective serotonin reuptake inhibitors (SSRIs), other antidepressants, or sleep medicines may be used. Choice depends on age, other drugs, and side-effect profiles. The goal is not simply to change mood but to support coping and quality of life.

10. Treatment of co-existing conditions
    People with CMT2U may also have other health problems, such as diabetes or thyroid disease, that can worsen neuropathy. Good control of blood sugar, vitamin levels (B12, D, etc.), and thyroid function is part of the medical treatment plan. Correcting these does not remove the MARS mutation but can reduce extra damage to nerves and improve strength or sensation.

---

Dietary molecular supplements

No supplement has been proven to cure or stop CMT2U, but some nutrients are being studied for general nerve health and antioxidant support. Any supplement should be discussed with a doctor because high doses can be harmful or interact with medicines.

1. Alpha-lipoic acid – An antioxidant that may support nerve blood flow and reduce oxidative stress. Research in diabetic neuropathy suggests small improvements in pain and function in some people, but data in CMT are limited. Typical study doses are around 600 mg per day, but long-term safety and ideal dosing need medical guidance.

2. Acetyl-L-carnitine – This molecule helps with energy production in mitochondria. Some small studies in nerve damage suggest possible benefit for pain and nerve regeneration. Doses in research have ranged from about 500–1000 mg two or three times daily. It may cause mild nausea or restlessness in some people.

3. Omega-3 fatty acids (fish oil) – Omega-3 fats from fish oil have anti-inflammatory and membrane-stabilizing effects. They may support general cardiovascular and nerve health. Common supplemental doses are 1–3 g per day of combined EPA and DHA, but high doses can affect bleeding risk, especially with blood-thinning medicines.

4. Vitamin B12 (methylcobalamin) – B12 is essential for normal myelin and nerve function. If a person has B12 deficiency, replacing it can improve neuropathy symptoms. Doses vary from low daily tablets to high-dose injections depending on deficiency severity and absorption. Taking very high doses without deficiency usually does not add benefit.

5. Vitamin D – Vitamin D supports bone, muscle, and immune health. Low levels are common in many populations and can worsen muscle weakness or pain. Correcting deficiency with daily or weekly vitamin D, under medical supervision, may help overall function and reduce fall risk.

6. Vitamin B1 (thiamine) and benfotiamine – Thiamine helps in nerve energy metabolism. Benfotiamine is a fat-soluble form sometimes studied in diabetic neuropathy. If levels are low, replacement can be helpful. Over-supplementation without monitoring is not recommended.

7. Coenzyme Q10 – CoQ10 is a mitochondrial cofactor with antioxidant properties. It has been tested in some neuromuscular and mitochondrial disorders. Possible benefits include reduced fatigue and improved exercise tolerance. Typical supplements range from 100–300 mg/day, but evidence is still limited.

8. Magnesium – Magnesium is important for muscle relaxation and nerve excitability. For people with low levels or muscle cramps, moderate supplements may help, but higher doses can cause diarrhea or interact with certain heart and kidney conditions.

---

Immune-booster, regenerative and stem-cell-related approaches

For autosomal dominant CMT2U, there are no approved immune-booster or stem-cell drugs that fix the disease. However, research areas include:

1. Gene-targeted therapies
   Scientists are exploring gene-editing and gene-replacement strategies for CMT in general. For MARS-related CMT2U, future approaches may aim to correct the mutant gene or balance expression of healthy MARS enzyme. At present, this work is mainly in laboratory and animal models, not standard clinical care.IUBMB Journal+1

2. Stem-cell based Schwann cell support
   Some experimental studies are looking at transplanting stem-cell-derived Schwann cells (the cells that wrap around peripheral nerves) to support damaged axons. Very early-phase trials in other neuropathies are trying to see if transplanted cells can improve nerve conduction. These techniques are complex, expensive, and not yet available as routine treatment.

3. Neurotrophic growth factor therapies
   Molecules such as nerve growth factor (NGF) and other neurotrophins have been tested in peripheral neuropathies. They aim to promote nerve survival and regeneration. So far, clinical results have been mixed, and side effects have limited their use. Larger, better trials are needed before any routine therapy is recommended.

4. General immune support and infection prevention
   Although CMT2U is not an immune disease, good vaccination status, prompt treatment of infections, and healthy lifestyle (sleep, diet, exercise) support the immune system. This reduces stress on the body and can indirectly help people maintain function and energy.

Because these approaches are not yet standard, there are no agreed doses or schedules. They should only be tried in properly regulated clinical trials.

---

Surgical options

Surgery does not repair nerves but can correct deformities and improve function or reduce pain.

1. Foot and ankle corrective surgery
   When braces and orthotics are not enough, orthopedic surgeons may correct high arched feet, claw toes, or severe deformity. They can realign bones, release tight tendons, or fuse unstable joints. The main goals are to improve foot alignment, make shoe fitting easier, reduce pain, and improve walking stability. Recovery includes physiotherapy and temporary limited weight-bearing.

2. Tendon transfer procedures for foot drop
   In tendon transfer surgery, a stronger tendon from one muscle is moved to help lift the foot where the muscles are weak. For example, a tendon that still has good strength may be reattached to the top of the foot to replace the function of a weak dorsiflexor. This can reduce tripping and may allow lighter braces or sometimes no brace at all, depending on overall strength.

3. Spinal surgery for scoliosis or severe deformity
   Some people with neuromuscular diseases develop significant spinal curvature. If scoliosis becomes severe and affects balance or breathing, spinal fusion or other corrective surgery may be suggested. This surgery is major and requires careful risk–benefit discussion and long rehabilitation.

4. Soft-tissue releases and joint stabilization
   In cases of very tight Achilles tendon or joint contractures, surgeons may lengthen tendons or release tight structures to allow better range of motion. In unstable joints, they may stabilize ligaments. These procedures aim to make bracing more effective, reduce pain, and improve gait.

---

Prevention of complications

Because the gene change cannot be prevented once inherited, prevention focuses on avoiding extra nerve damage and long-term complications.

1. Avoid known nerve-toxic medicines where possible (certain chemotherapy drugs, very high-dose vitamin B6, some antibiotics), after discussion with doctors.

2. Limit or avoid alcohol and smoking, which can worsen nerve damage and circulation.

3. Maintain healthy body weight to reduce strain on weak muscles and joints.

4. Use proper footwear, braces, and walking aids to prevent falls, sprains, and fractures.

5. Do regular physiotherapy and stretching to prevent contractures and severe deformities.

6. Inspect feet daily for blisters, pressure areas, or wounds, especially if sensation is reduced.

7. Treat infections quickly and keep vaccinations up to date to avoid long hospital stays that can weaken muscles.

8. Attend regular follow-up with neuromuscular specialists to adjust braces, orthotics, and treatment as the disease changes.Muscular Dystrophy Association+3nhs.uk+3Mayo Clinic+3

---

When to see doctors

A person with CMT2U should see a doctor, ideally a neurologist, regularly, but urgent review is important if:

• Walking suddenly becomes much harder, with new or rapid weakness.

• There is new severe pain, burning, or electric-shock sensations that do not respond to usual measures.

• There are foot sores, ulcers, or infections that do not heal, or signs of spreading infection such as fever.

• There are frequent falls or near-falls, especially with head injury or fractures.

• There is new spine curvature, severe back pain, or breathing problems.

• Mood changes such as strong sadness, hopelessness, or anxiety interfere with daily life.

• A person with CMT2U is planning a pregnancy or wants genetic counseling for future children.

Prompt assessment helps adjust physiotherapy, braces, and medicines, and may prevent permanent damage or disability.Mayo Clinic+2ScienceDirect+2

---

What to eat and what to avoid

Food cannot cure a genetic neuropathy, but a balanced diet supports muscle, nerve, and bone health and helps maintain a healthy weight.

Helpful to eat more often

1. Whole grains (brown rice, oats, whole-wheat bread) for steady energy.

2. Lean proteins (fish, chicken, beans, lentils, tofu) to support muscle repair.

3. Colorful fruits and vegetables rich in vitamins and antioxidants (berries, citrus, leafy greens).

4. Healthy fats from nuts, seeds, olive oil, and fatty fish (omega-3s).

5. Calcium- and vitamin-D-rich foods (milk, yogurt, fortified plant milks, small bony fish) for bones.

Better to limit or avoid

1. Excessive sugary drinks and sweets, which can promote weight gain and diabetes.

2. Very salty processed foods (chips, packaged snacks) that can worsen blood pressure and swelling.

3. Trans-fat-rich fried fast foods that increase inflammation and heart risk.

4. Alcohol, which can directly damage nerves and affect balance and judgment.

5. Smoking or vaping nicotine products, which harm blood vessels and nerve health.

A dietitian who understands neuromuscular disease can make an individual plan that matches age, culture, and local food availability.

---

Frequently asked questions (FAQs)

1. Is CMT2U due to MARS mutation curable?
   No. At this time there is no cure or gene-editing treatment for CMT2U. Management focuses on long-term rehabilitation, braces, and symptom control.

2. Will everyone with the mutation have the same symptoms?
   No. Even in the same family, some people can have mild problems and others more severe disability. Age of onset, rate of progression, and pain levels can vary widely.SAGE Journals+2MalaCards+2

3. Does this disease shorten life?
   Most people with CMT, including many forms of CMT2, have near-normal life expectancy, though disability and fatigue can be important. Severe deformities or complications (like bad falls) can affect health but are often preventable with proper care.Mayo Clinic+1

4. Can exercise make the disease worse?
   Well-planned, low-to-moderate intensity exercise designed by a physiotherapist is usually safe and helpful. Very heavy, high-impact or over-fatiguing exercise might increase injury risk, so programs must be tailored.Physiopedia+2PMC+2

5. Is pain always present?
   Some people mainly have weakness and almost no pain. Others have burning or electric-like nerve pain and muscle cramps. Pain can often be improved with a mix of physiotherapy, self-management, and medicines such as gabapentin, pregabalin, or duloxetine.nhs.uk+2Mayo Clinic+2

6. Can children be tested for the MARS mutation?
   Genetic testing is possible, but whether and when to test children is a complex ethical decision. Genetic counseling is recommended before testing to discuss benefits, risks, and timing.MalaCards+1

7. Are there special medicines only for CMT2U?
   Right now, there are no drugs designed only for CMT2U. Most medicines used are general neuropathic pain treatments, and they are chosen based on symptoms rather than the exact gene.ScienceDirect+1

8. Is pregnancy safe for someone with CMT2U?
   Many women with CMT have successful pregnancies. However, extra weight and joint laxity may worsen weakness or balance, and there is a chance of passing on the gene. Pre-pregnancy counseling with neurology, obstetrics, and genetics is helpful.ScienceDirect+1

9. Should people with CMT2U avoid surgery or anesthesia?
   Most surgeries are possible with careful planning. The anesthesiologist must know about the neuropathy, and nerve-toxic medicines should be avoided when possible. Orthopedic surgery is sometimes necessary to improve function rather than being dangerous in itself.

10. What research is happening now?
    Current research includes better understanding of how MARS mutations damage axons, developing cell and animal models, and exploring gene-targeted or regenerative therapies. Clinical trials for CMT more broadly test new medicines and rehabilitation strategies. Patients can ask their neurologist or local neuromuscular center about ongoing trials.IUBMB Journal+2PMC+2

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 22, 2025.